Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Overactive Bladder Syndrome
Open-data reference.
13 US clinical trials · 8 currently recruiting
Active & Recent Trials
BTL Emsella Chair Versus Sham for the Treatment of Overactive Bladder
Corewell Health East
NCT04873037
Vaginal Estradiol vs Oral Beta-3 Agonist for Overactive Bladder Syndrome
Walter Reed National Military Medical Center
NCT05221021
Oxybutynin for Post-surgical Bladder Pain and Urgency
University of California, Davis
NCT03952299
Examining the Effects of Intra-detrusor Botox at Time of HoLEP in Men With Overactive Bladder Symptoms
Northwestern University
NCT05878951
Testing MitoQ on Lower Urinary Tract Symptoms in Older Women With Metabolic Syndrome
Iman Al-Naggar, PhD
NCT06351683
Yoga for Treatment of Overactive Bladder in Pediatric Patients
Duke University
NCT05895045
Improving Overactive Bladder Treatment Access and Adherence
Stanford University
NCT06094543
rTMS in Overactive Bladder
The Methodist Hospital Research Institute
NCT06198439
Cyclic Versus Continuous Sacral Neuromodulation for LUTS
University Hospitals Cleveland Medical Center
NCT06170450
A 12-Week Study to Evaluate the Efficacy of Darifenacin to Increase the Warning Time in Patients With Overactive Bladder.
Novartis
NCT00171145
Intradetrusor Botulinum Toxin A for OAB Via 1 Versus 10 Injections: A Randomized Clinical Trial
University of California, Irvine
NCT05308979
Prophylactic Antibiotic Administration for Bladder OnabotulinumtoxinA Injection
The Cleveland Clinic
NCT05719285
Long-Term Open-Label Extension Trial for Subjects Completing the Phase 3 Trial of Fesoterodine (SP584) for the Treatment of Overactive Bladder Syndrome
Pfizer
NCT00220376
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 2 |
| Phase 3 | 3 |
| Phase 4 | 3 |
Top Sponsors
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Reading the Overactive Bladder Syndrome Trial Landscape
ClinicalTrials.gov lists 13 US studies indexed under Overactive Bladder Syndrome, and 8 of those are currently open to recruitment — roughly 62% of the total volume on the registry. That ratio is a useful proxy for activity level: a high share of recruiting studies often signals that research interest is current and that new enrollment opportunities are appearing, while a low share typically means the field is dominated by completed or follow-up work where most participant spots have already been filled. These counts reflect the public registry only and include studies at every stage of design, so they should be read as an index of research attention rather than as a measure of treatment availability.
The phase distribution for Overactive Bladder Syndrome shows 6 late-stage studies (Phase 3 and Phase 4 combined) alongside 2 earlier-phase entries (Phase 1 through Phase 2). Phase 1 and Phase 2 studies focus on early safety signals, dosing, and preliminary effect, while Phase 3 studies are typically the larger efficacy and safety trials submitted toward regulatory review, and Phase 4 studies follow approved interventions in real-world use. A condition weighted toward later phases often reflects a mature research pipeline with several interventions already close to or past approval, whereas a heavier early-phase tilt suggests the field is still exploring new mechanisms and candidate approaches.
Top sponsor activity for Overactive Bladder Syndrome is led by Novartis with 1 indexed trial, alongside 9 other organizations in the top contributor list. The list on this page surfaces up to 13 of the most relevant recent and active entries, ordered with recruiting studies first so practical options are visible. All figures are derived from the public ClinicalTrials.gov dataset maintained by the National Library of Medicine and are reproduced here for reference. Inclusion of a trial, sponsor, or intervention on this page is neither an endorsement nor a recommendation — eligibility, protocol changes, and site-level status can shift frequently, so always verify current details on ClinicalTrials.gov and consult a qualified healthcare provider before acting on anything you see here.
Frequently Asked Questions
How many clinical trials are there for Overactive Bladder Syndrome?
PlainTrial tracks 13 US clinical trials for Overactive Bladder Syndrome, of which 8 are currently recruiting participants. Data sourced from ClinicalTrials.gov.
How do I find a recruiting trial for Overactive Bladder Syndrome?
Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.
Is this data current?
Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.
Related
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.
Read our methodology — how this data is sourced, computed, and verified.
Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2024 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.